Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 1066 AL 1080

Levodopa and neuropathy risk in patients with Parkinson disease: Effect of COMT inhibition

Cossu G, Ceravolo R, Zibetti M, Arca R, Ricchi V, Paribello A, Murgia D, Merola A, Romagnolo A, Nicoletti V, Palermo G, Mereu A, Lopiano L, Melis M, Abbruzzese G, Bonuccelli U.

Parkinsonism Relat Disord. 2016 Jun;27:81-4. doi: 10.1016/j.parkreldis.2016.04.016. Epub 2016 Apr 20.

[The role of neuroinflammation-related regulatory targets in the treatment for Parkinson’s disease]

Zang CX, Bao XQ, Sun H, Zhang D.

Yao Xue Xue Bao. 2016 May;51(5):677-83.

[Progress and perspective of silkworm as a model of human diseases for drug screening]

Chen M, Song JB, Li ZQ, Tang DM, Tong XL, Dai FY.

Yao Xue Xue Bao. 2016 May;51(5):690-7.

Statin use and risk of Parkinson's disease: A meta-analysis

Sheng Z, Jia X, Kang M.

Behav Brain Res. 2016 Aug 1;309:29-34. doi: 10.1016/j.bbr.2016.04.046. Epub 2016 Apr 27.

Gene therapy to target ER stress in brain diseases

Valenzuela V, Martínez G, Duran-Aniotz C, Hetz C.

Brain Res. 2016 Oct 1;1648(Pt B):561-570. doi: 10.1016/j.brainres.2016.04.064. Epub 2016 Apr 27.

Parkinson's disease, visual hallucinations and apomorphine: A review of the available evidence

Borgemeester RW, Lees AJ, van Laar T.

Parkinsonism Relat Disord. 2016 Jun;27:35-40. doi: 10.1016/j.parkreldis.2016.04.023. Epub 2016 Apr 22.

Micrographia following bilateral subthalamic nucleus deep brain stimulation

Fearon C, Vijayashankar P, Olszewska DA, Goggin C, Magennis B, Quigley G, Lynch T.

Parkinsonism Relat Disord. 2016 Jul;28:161-2. doi: 10.1016/j.parkreldis.2016.04.004. Epub 2016 Apr 13.

Neuromodulation for restoring memory

Bick SK, Eskandar EN.

Neurosurg Focus. 2016 May;40(5):E5. doi: 10.3171/2016.3.FOCUS162.

Lysosomal Acid Phosphatase Biosynthesis and Dysfunction: A Mini Review Focused on Lysosomal Enzyme Dysfunction in Brain

Ashtari N, Jiao X, Rahimi-Balaei M, Amiri S, Mehr SE, Yeganeh B, Marzban H.

Curr Mol Med. 2016;16(5):439-46. doi: 10.2174/1566524016666160429115834.

The association between the LRRK2 R1628P variant and the risk of Parkinson's disease in Asian: a meta-analysis

Wang X, Zhang X, Xue L, Xie A.

Neurosci Lett. 2016 Jun 3;623:22-7. doi: 10.1016/j.neulet.2016.04.056. Epub 2016 Apr 28.

Oral r-(-)-11-o-valeryl-n-n-propylnoraporphine reverses motor deficits in mptp-treated marmosets

Lincoln L, Fisher R, Jackson MJ, Jenner P, Neumeyer J, Sromek AW, Lees AJ, Rose S.

Mov Disord. 2016 Sep;31(9):1381-8. doi: 10.1002/mds.26626. Epub 2016 May 2.

Mutation in ADORA1 identified as likely cause of early-onset parkinsonism and cognitive dysfunction

Jaberi E, Rohani M, Shahidi GA, Nafissi S, Arefian E, Soleimani M, Moghadam A, Arzenani MK, Keramatian F, Klotzle B, Fan JB, Turk C, Steemers F, Elahi E.

Mov Disord. 2016 Jul;31(7):1004-11. doi: 10.1002/mds.26627. Epub 2016 May 2.

Protein biomarkers in Parkinson's disease: Focus on cerebrospinal fluid markers and synaptic proteins

Halbgebauer S, Öckl P, Wirth K, Steinacker P, Otto M.

Mov Disord. 2016 Jun;31(6):848-60. doi: 10.1002/mds.26635. Epub 2016 May 2.

Targeting the dopamine D3 receptor: an overview of drug design strategies

Cortés A, Moreno E, Rodríguez-Ruiz M, Canela EI, Casadó V.

Expert Opin Drug Discov. 2016 Jul;11(7):641-64. doi: 10.1080/17460441.2016.1185413. Epub 2016 May 30.

Phthalocyanines as Molecular Scaffolds to Block Disease-Associated Protein Aggregation

Valiente-Gabioud AA, Miotto MC, Chesta ME, Lombardo V, Binolfi A, Fernández CO.

Acc Chem Res. 2016 May 17;49(5):801-8. doi: 10.1021/acs.accounts.5b00507. Epub 2016 May 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias